Li, Ting <br/><br/>
Novel Hsp90 inhibitor platycodin D disrupts Hsp90/Cdc37 complex and enhances the anticancer effect of mTOR inhibitor.  [electronic resource] 

 -  Toxicology and applied pharmacology  09 2017 
 - 65-73 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1096-0333 
<br/><br/><label>Standard No.: </label>10.1016/j.taap.2017.07.006  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--pharmacology<br/>Apoptosis--drug effects<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>Cell Cycle Proteins--drug effects<br/>Cell Proliferation--drug effects<br/>Chaperonins--drug effects<br/>ErbB Receptors--antagonists & inhibitors<br/>Everolimus--pharmacology<br/>HSP90 Heat-Shock Proteins--antagonists & inhibitors<br/>Humans<br/>Immunosuppressive Agents--pharmacology<br/>Lung Neoplasms--drug therapy<br/>Oncogene Protein v-akt--antagonists & inhibitors<br/>Receptor, IGF Type 1<br/>Receptors, Somatomedin--antagonists & inhibitors<br/>Saponins--toxicity<br/>TOR Serine-Threonine Kinases--antagonists & inhibitors<br/>Triterpenes--toxicity